FON- The Rise of the Multifamily Office
Come join Family Office Networks for a discussion looking at how family offices are pooling resources to create synergies and generate alpha. Andrew P Schneider, Founder of Family Office Networks will be leading the presentation.
AVG – Seeding the Future: Accessing Proprietary Seed & Pre-Seed Stage VC Deals
join the Family Office Networks’ Webinar Series featuring Alumni Venture Group. AVG, one of the nation’s most active pre-seed and seed venture investors, will show how individual and family investors can most effectively access promising early stage deals. They will walk through the keys of creating a smart seed portfolio by leveraging the Power Law, applying disciplined quality checks, and investing alongside established seed syndicates. They will also explain the importance of portfolio diversification and the “chase the winner” strategies deployed by top seed investor shops.
Hear from AVG’s CEO and a Managing Partner from AVG’s Basecamp Fund, dedicated to seed investing, as they share their approach to seed deal selection and diversified portfolio creation. AVG will also outline its own investment funds and opportunities, with a special focus on seed and pre-seed stage opportunities. Finally, the presenters will bring the investment process to life with a sample of AVG seed deals.
Synergy Disk – Private Investment Opportunity in a Disruptive Spinal Disc Technology
Come Join the Family Office Networks Webinar Series Featuring Synergy Disc®. A Canadian medical device company dedicated to developing and commercializing next generation, minimally invasive spine technologies.
SDRi’s marquee technology, the Synergy Disc, is the only artificial disc on the market that addresses motion and alignment for the treatment of degenerative disc disease in the cervical spine.
The Technology:
Synergy Disc ® is protected by over 55 patents
Addressing alignment can expand the market to >50% more patients
Over 950 Synergy Disc implants have been performed without any reported adverse events
Early sales in UK, Germany & Australia
Single-Arm FDA clinical trial starting in Oct 2020
The Investment Opportunity:
SDRi is seeking $15M to complete its IDE clinical trial enrollment and 2-year follow-up, achieve US FDA PMA approval to access the US market, and fuel its outside the USA market opportunity. SDRi already has commitments for >$3M from existing shareholders.
Validated by Strategic Shareholder – Top 3 Public Spine Device Company
Prior exits in the spine artificial disc technology space have ranged from ~$100M – $1B, with an average exit value of $360M. With an attractive pre-money valuation of $41M, SDRi has promising return potential.
IIX – The Award-Winning Women’s Livelihood Bond Series
Come join the Family Office Network’s Webinar Series featuring the Women’s Livelihood Bond Series and find out why it is attracting investors from U.S, Europe, Australia and Asia.
The US$150 million Women’s Livelihood Bond Series are high yield debt securities that finance a portfolio of women-focused SMEs in Asia Pacific, and are generating social and financial return for investors. Even in the face of COVID-19 and the economic downturn, the Women’s Livelihood Bond Series has been beating the market.
Want to catch the ESG wave? Join the session and hear about:
How past issuances are delivering social and financial returns to investors
The details of the next issuance
How investors can rebuild our economies and COVID-resilience through the Bond
OXIO Health: US Healthcare Segment
Join the Family Office Networks community and the management team from OXIO Health, Inc. (OXIO) as they discuss solutions to the current healthcare crisis and the multiple opportunities they have created with industry leadership that brings an outstanding investment opportunity with High Societal Impact.
OXIO is the parent company of an initial group of five (5) innovative and relational companies that are poised to enter the market in Q4 2020 to address a number of systemic healthcare problems which are now reaching a breaking point due to the COVID-19 crisis. Healthcare is both the largest industry in the USA and the most complex with healthcare costs forecast to nearly double to more than US$6 trillion in the coming decade.
What you will hear in this webinar:
How this addressable market of nearly $400 B in healthcare in these segments has limited competition and how OXIO is poised make an impact in a short period of time
How a skilled and experienced management team is bringing all these areas under one roof to capitalize on the tremendous economies of scale this creates as well as leveraging its robust IP that could change healthcare permanently
How can anyone ignore an opportunity where public companies are selling for 10-30X revenues and companies filing IPOs see share prices double on opening day?
You are invited to listen to OXIO’s top industry healthcare experts, visionaries and thought leaders talk about a new type of enterprise that brings technology to the care of patients, including the Medicare population that is growing at a rate of 10,000 persons a day. The team has also developed an innovative capital structure that will allow quick monetization as the company expands. OXIO combines the features of an incubator/accelerator and behaves more like venture capital, thus approaching private equity that it calls a Distributive Venture Platform™. This is a must hear presentation.
Equinox Partners – 10 Rules for Investing in Gold Mining
Join the Family Office Networks’ Webinar Series featuring Equinox Partners.
Gold has proven to be a liquid, uncorrelated asset ideally suited for the current era of uncertainty. With extreme valuations in U.S. equities, very low interest rates, and experimental central bank intervention, the tailwinds for gold are significant. At the same time, precious metals miners are trading at low valuations coupled with a scarcity of active managers willing or able to pick stocks after a prolonged bear market. Equinox Partners, a Connecticut-based investment manager that runs several funds and managed accounts, has over 20 years’ experience in the precious metals mining sector as long-term, contrarian, value investors. The firm’s CIO, Sean Fieler, will lead a discussion on the 10 rules the firm applies to analyzing investments in the sector.
Lake Nona Performance Club – Promoting Investments in Integrated Wellness Through Strategic Partnerships
Join the Family Office Networks’ Webinar Series featuring The Lake Nona Performance Club.
Under construction and scheduled to open in July 2021, the Lake Nona Performance Club (LNPC) in Orlando will be one of the most thoughtfully curated and all-inclusive health and wellness centers in the nation. It provides a tailored approach to whole-person health for members of all ages and skill levels and empowering participants to overcome injury and disease. The 130,000-square-foot center will redefine the fitness center experience for the region with leading-edge workout equipment, state-of-art classes, and interactive programs driven by the latest performance
technology.
LNPC is located in the heart of the 6 million sq. ft. Lake Nona Town Center. This forward-thinking region is transforming the concept of healthy living for the 300,000+ who live and work in this modern mecca for technology and innovation in Orlando.
SoulPhysio – Combating Mental & Neurological Illness in the Next Generation
Join the Family Office Networks Webinar Series Featuring the SoulPhysio Foundation. Aneesh Chaudhry, Philanthropist will share how SoulPhysio will Combat Mental and Neurological Illness in Children, with their primary focus being ASD (Autistic Spectrum Disorder).
Their methods focus on bridging the gap between Eastern and Western Medicine to conduct research and fund treatment for complex Mental and Neurological cases at both of their Southern California clinics. They plan to Implement cutting edge wellness programs for inner city schools and families.
What you will learn from this webinar:
The future of treating Mental and Neurological Illness in children
The Mindful Classroom and it’s focus on providing accessible wellness services to inner city schools and families
The long-term vision of becoming a multi-billion dollar social enterprise
Medical Synergies – Naturally Boosting Immune Systems to Combat Disease
Come Join the Family Office Networks’ Webinar Series featuring Asalyxa Bio. Asalyxa Bio’s elegant technology platform enables targeted delivery of therapeutic compounds directly to neutrophils, a key immune cell with relevance to various acute diseases/conditions including COVID-19. This platform is ideal for a variety of diseases where treatments are limited or do not exist.
Diversifying your Cancer Immunotherapy Investments with B cell Activation Approaches
Background on Company
Novel scientific insights to unlock the full potential of B cell therapeutics
Range of treatment opportunities for cancer immunotherapy and B cell-driven rare diseases
Lead program, AT-1965, advancing toward IND and initiation of solid tumor clinical study in 2H2020
Positive pre-IND interaction with FDA; alignment on 2020 IND submission and clinical initiation for AT-1965
Collaborative team with leadership across all biotech disciplines; premier scientific advisors and leading entrepreneur backers
Financing underway to fund AT-1965 clinical initiation and development
What you will learn from this webinar
How a B cell activation approach differs from other cancer immunotherapy approaches
How clinical data drives value creation in cancer immunotherapy
How AT-1965 is poised to lead the next frontier in cancer immunotherapy
How investment in Akamara will diversify your cancer immunotherapy portfolio
Hemptown USA has generated $17.6 million in revenue for 2019 and closed $23M in funding through 2 capital raises.
What you will learn from this webinar:
About hemp-derived cannabinoids and how Hemptown USA became an established and experienced operator in this emerging industry.
The hemp value chain, and Hemptown USA’s diversified revenue approach.
What is CBG and why it is the next big cannabinoid.
Why Hemptown USA’s production platform and M&A strategy present a unique opportunity for investors.